News related to Revlimid (Lenalidomide) and/or conditions it is approved for
REVLIMID (lenalidomide) approved by the European Commission for the treatment of relapsed/refractory patients with mantle cell lymphoma
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.07.18]
Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation has announced that the European Commission (EC) has approved REVLIMID® (lenalidomide) for the treatment of adult...
Source: MedicineNet Carpal Tunnel Syndrome Specialty [2016.04.01]
Title: Multiple Myeloma
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 4/1/2016 12:00:00 AM
New drug class gives hope for better treatments for incurable myeloma
Source: Cancer / Oncology News From Medical News Today [2016.08.10]
Australian researchers have discovered that a new class of anti-cancer agents may be effective in treating multiple myeloma, an incurable bone marrow cancer.